SOPHiA GENETICS SA operates as a healthcare technology company. The company offers SOPHiA DDM platform, a cloud-based software-as-a-service platform for analyzing data and generating insights from multimodal data sets and diagnostic modalities. Its SOPHiA DDM platform and related solutions, products, and services are used by hospital, laboratory, and biopharma worldwide. SOPHiA GENETICS SA was incorporated in 2011 and is headquartered in Saint-Sulpice, Switzerland.

• Download SqueezeTrigger (TM) Report
• Download FrictionFactor Report
• Download Daily Short Volume Report
• Download Real-Time Short Volume Tool
• Download Failures to Deliver

• [09/02/2025 13:20 PDT] SOPHiA GENETICS SA (NASDAQ:SOPH), Down By 100% ($3.61) From $3.61 After BUYINS.NET Report Predicted Stock Would Go Down Due To Bearish Conditions
• [08/25/2025 07:19 PDT] SOPH Expected to Trade Down After Bearish Patterns Develop
• [08/21/2025 11:08 PDT] SOPHiA GENETICS SA (NASDAQ:SOPH), Up By 100% ($3.16) From $3.16 After BUYINS.NET Report Predicted Stock Would Go Up Due To Bullish Conditions
• [08/04/2025 07:16 PDT] SOPH Expected to Trade Up After Bullish Patterns Develop
• [07/31/2025 07:25 PDT] SOPH Expected to Trade Up After Bullish Patterns Develop
• [07/23/2025 07:06 PDT] SOPH Expected to Trade Up After Bullish Patterns Develop